Experiment: 7DAC

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D DARR 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
15	2D DARR 200ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
16	2D DARR 500ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
2	2D NcaCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
3	2D NcoCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
4	3D NCACX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
5	3D NCOCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
17	zTEDOR 6.4ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
19	zTEDOR 8.5ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
18	2D RFDR 10.7ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
20	2D INEPT-TOBSY	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
6	2D DARR 50ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
7	2D DARR 200ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
8	2D DARR 500ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
21	zTEDOR 6.4ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
22	zTEDOR 8.5ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
37	2D NcaCX 50ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
38	2D NcoCX 50ms mixing	5 mg/mL [U-100% 2-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
9	2D DARR 50ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
10	2D DARR 200ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
11	2D DARR 500ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
24	zTEDOR 6.4ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
26	zTEDOR 8.5ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
39	2D NcaCX 50ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
40	2D NcoCX 50ms mixing	5 mg/mL [U-100% 1, 3-13C Glycerol; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
12	2D DARR 50ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
13	2D DARR 200ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
14	2D DARR 500ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
27	zTEDOR 6.4ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
28	zTEDOR 8.5ms mixing	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
29	2D NHHC	5 mg/mL [U-50% 13C; natural abundance N][natural abandance 13C; U-50% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Bruker AVANCE NEO 700
30	2D DARR 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
31	2D DARR 200ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
32	2D DARR 500ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
33	2D NcaCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
34	2D NcoCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
35	3D NCACX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700
36	3D NCOCX 50ms mixing	5 mg/mL [U-100% 13C; U-100% 15N] human RIPK3 fibrils	95% H2O/5% D2O	0 mM	7.5	1 atm	298	Agilent Direct Drive 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	700
2	Agilent	Direct Drive	700

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	96
Conformers Submitted Total Number	12
Representative Model	1 (medoid)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
2	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	Sparky		Goddard
4	peak picking	Sparky		Goddard

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

7DAC

Human RIPK3 amyloid fibril revealed by solid-state NMR